
Natasha Singhal
Consultant
London, UK
Natasha Singhal is a consultant in the Milliman London Healthcare Practice. She joined Milliman in 2012, working primarily in the UK market but also with material international experience.
Experience
Natasha’s experience spans traditional actuarial and clinical analysis with key areas, including:
- Conducting actuarial consulting services to private and public healthcare providers within the UK
- Pricing healthcare products domestically and internationally, including reviewing product designs and building bespoke pricing models for new startups
- Performing capital analysis and Solvency II regulatory reporting, including:
- Building a healthcare-specific SCR model for a UK healthcare provider, including the calculation of Undertaking-Specific-Parameters (USP)
- Calculating capital injection required to reach capital adequacy for an international healthcare provider
- Reviewing capital models whilst supporting chief actuary roles
- Running experience analysis on past data, including data manipulation to create multiways, formulating and running GLM models and factor analysis
- Manipulating large healthcare datasets using SAS and SQL for various projects, including overseeing the development of the Milliman UK Health Cost Guidelines.
- Ad-hoc and business focused investigations and analysis on drivers of claims experience using large claims data sources, with a deep understanding of healthcare claims data.
- Reserving for health insurers.
- Modelling care pathways for medical management
Natasha has undertaken several secondments over the years, with work ranging from building product specific pricing models, providing pricing expertise in a reviewer capacity, building an internal model to calculate the impact of climate change on an international book alongside reserving reviews. Clients have included Bupa Global, Bupa UK, AXA and The Exeter.
Publications and Presentations
- https://uk.milliman.com/en-GB/insight/Looking-at-cancer-trends-through-Milliman-UK-Health-Cost-Guidelines
- https://uk.milliman.com/en-GB/insight/Value-of-care-categories
- https://uk.milliman.com/en-GB/insight/Emerging-risks-in-insurance-Climate-change
- https://uk.milliman.com/en-GB/insight/Role-of-data-in-transforming-UK-private-medical-insurance-analytics
- https://uk.milliman.com/en-GB/insight/A-case-study-Risk-adjustment-in-the-UK-PMI-market
- https://uk.milliman.com/en-GB/insight/The-role-of-wearables-in-private-medical-insurance
- https://uk.milliman.com/en-GB/insight/Peer-review-Performance-metrics-for-premier-specialist-consultants-relative-to-nonpremier
- https://uk.milliman.com/en-GB/insight/Actuarial-benchmarking-of-inpatient-admissions-within-England-using-international-comparators
Professional Designations
- FIA C.Act – Chartered Actuary (Fellow), Institute and Faculty of Actuaries (UK)
Education
- London School of Economics and Political Science, Honours in BSc Business Mathematics and Statistics
Publications
Read their latest work
Article
Analysing 2023 Solvency and Financial Condition Reports (SFCRs) of health insurers in the UK
09 October 2024 - by Joanne Buckle, Natasha Singhal, Somya Bansal, Kunal Panjwani
We provide some insights to the year-end 2023 SFCRs of selected health insurers with domestic medical insurance business in the United Kingdom.
Article
Market insight from year-end 2022 SFCRs: Analysis of health insurers based in the UK
31 October 2023 - by Joanne Buckle, Natasha Singhal, Somya Bansal
We offer some insights to the year-end 2022 SFCRs of selected health insurers with domestic medical insurance business in the United Kingdom.
Article
COVID-19 and medical underwriting practices for life and health insurance
03 February 2023 - by Natasha Singhal, Vincent Soulas, Lalit Baveja
As more evidence emerges about long-term clinical impacts of Covid-19 and long Covid, insurers will need to consider the implications for medical underwriting.
Article
Analysis of insurers’ Solvency and Financial Condition Reports
19 July 2022 - by Joanne Buckle, Natasha Singhal
UK health insurers had strong positions at year-end 2021, with a weighted average SCR coverage ratio of 177%, though down from 198% a year earlier.
Article
Approaches to measuring climate change impacts for medical insurers
31 May 2022 - by Joanne Buckle, Alexander Krauskopf, Natasha Singhal
Using historical data in the U.K. and Germany to help medical insurers better understand the morbidity and mortality risks from climate change
Article
Analysis of insurers’ Solvency and Financial Condition Reports: UK domestic medical insurers and IPMI markets
12 October 2021 - by Joanne Buckle, Natasha Singhal
UK health insurers showed strong positions at year-end 2020, with a weighted average SCR coverage ratio of 198%, versus 178% in 2019.
Article
Peer review: Performance metrics for premier specialist consultants relative to non-premier consultants
14 June 2021 - by Joanne Buckle, Tanya Hayward, Natasha Singhal
A new form of measurement: Does the frequency of change of original consultant measure performance for Vitality Health?
Article
Climate change ORSA guide: Capturing climate change in the ORSA
17 February 2021 - by Ian Penfold, Natasha Singhal, Sophie Smyth
In this paper, we discuss how insurance companies can consider the impact of climate change through their Own Risk and Solvency Assessment (ORSA).
Article
Actuarial benchmarking of inpatient admissions within England using international comparators
17 February 2021 - by Joanne Buckle, Natasha Singhal
England benchmarking of inpatient admissions identifies value opportunities.
Article
How is the English NHS prescription drugs budget spent? Third edition: FY 2019/20
27 January 2021 - by Joanne Buckle, Natasha Singhal, Kishan Desai
This report provides an updated view of National Health Service England prescription drug expenditure for FY 2019/20.